FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileALPS Medical Breakthroughs ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
SBIO
ALPS Medical Breakthroughs ETF ETF AnalysisComprehensive ETF analysis for ALPS Medical Breakthroughs ETF (SBIO) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisSBIO
SBIO
ALPS Medical Breakthroughs ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
SBIO
  1. Home
  2. Screener
  3. ALPS Medical Breakthroughs ETFSBIOETF
ALPS Medical Breakthroughs ETF Logo

ALPS Medical Breakthroughs ETF

ETF
🇺🇸SBIO•AMEX•Equity

Your view on SBIO

ALPS Medical Breakthroughs ETF Logo

ALPS Medical Breakthroughs ETF

ETFALPS Funds
🇺🇸SBIO•AMEX•Equity
AUM (USD)$187.10M
Expense Ratio0.5%
Holdings103

Sentiment

—

AUM (USD)

$187.10M

Expense Ratio

0.5%

Holdings

103

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

ALPS Medical Breakthroughs ETF (SBIO) is an Equity fund from ALPS Funds, listed since 2014, with $187.1M in assets under management, a 0.50% expense ratio and a NAV of $55.85 USD.

Overview for ALPS Medical Breakthroughs ETF

Fund Type
ETF
Fund Issuer
ALPS Funds
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 30, 2014
Domicile
US
Website
alpsfunds.com/exchange-traded-funds/SBIO
Fund Type
ETF
Fund Issuer
ALPS Funds
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 30, 2014
Domicile
US
Website
alpsfunds.com/exchange-traded-funds/SBIO
Fund Type
ETF
Fund Issuer
ALPS Funds
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 30, 2014
Domicile
US
Website
alpsfunds.com/exchange-traded-funds/SBIO

About this fund

The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.5%

AUM

$187.10M

Fund Details

NAV$55.85 USD
Holdings103
Average Volume38.9K
Inception DateDecember 30, 2014
Asset ClassEquity
Fund IssuerALPS Funds
DomicileUS
ISINUS00162Q5936
CUSIP00162Q593
NAV CurrencyUSD

Expense Ratio

0.5%

Assets Under Management

$187.10M

NAV

$55.85 USD

Holdings

103

Average Volume

38.9K

Inception Date

December 30, 2014

Asset Class

Equity

Fund Issuer

ALPS Funds

Domicile

US

ISIN

US00162Q5936

CUSIP

00162Q593

NAV Currency

USD

Expense Ratio

0.5%

Assets Under Management

$187.10M

NAV

$55.85 USD

Holdings

103

Average Volume

38.9K

Inception Date

December 30, 2014

Asset Class

Equity

Fund Issuer

ALPS Funds

Domicile

US

ISIN

US00162Q5936

CUSIP

00162Q593

NAV Currency

USD

Data last updated: Nov 13, 2026, 08:10 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

104 positions
1CGONCG oncology Inc.
5.04%
2ORKAOruka Therapeutics Inc.
4.49%
3MANEVeraDermics Inc.
3.61%
4DNTHDianthus Therapeutics Inc.
3.30%
5TVTXTravere Therapeutics Inc.
3.16%
6EWTXEdgewise Therapeutics Inc.
3.10%
7DFTXDefinium Therapeutics Inc.
2.75%
8XENEXenon Pharmaceuticals Inc.
2.53%
9VRDNViridian Therapeutics Inc.
2.48%
10RLAYRelay Therapeutics Inc.
2.42%
11TARSTarsus Pharmaceuticals Inc.
2.37%
12AMLXAmylyx Pharmaceuticals Inc.
2.29%
13ACADACADIA Pharmaceuticals Inc.
2.10%
14SLSSELLAS Life Sciences Group Inc.
2.09%
15DYNDyne Therapeutics Inc.
2.08%

Concentration

Total Holdings104
Top 10 Weight32.88%
Top HoldingCGON
Top Weight5.04%
1CGONCG oncology Inc.
5.04%
2ORKAOruka Therapeutics Inc.
4.49%
3MANEVeraDermics Inc.
3.61%
4DNTHDianthus Therapeutics Inc.
3.30%
5TVTXTravere Therapeutics Inc.
3.16%
6EWTXEdgewise Therapeutics Inc.
3.10%
7DFTXDefinium Therapeutics Inc.
2.75%
8XENEXenon Pharmaceuticals Inc.
2.53%
9VRDNViridian Therapeutics Inc.
2.48%
10RLAYRelay Therapeutics Inc.
2.42%
11TARSTarsus Pharmaceuticals Inc.
2.37%
12AMLXAmylyx Pharmaceuticals Inc.
2.29%
13ACADACADIA Pharmaceuticals Inc.
2.10%
14SLSSELLAS Life Sciences Group Inc.
2.09%
15DYNDyne Therapeutics Inc.
2.08%

Total Holdings

104

Top 10 Weight

32.88%

Top Holding

CGON

Top Weight

5.04%

1CGONCG oncology Inc.
5.04%$8.87M
2ORKAOruka Therapeutics Inc.
4.49%$7.90M
3MANEVeraDermics Inc.
3.61%$6.36M
4DNTHDianthus Therapeutics Inc.
3.30%$5.81M
5TVTXTravere Therapeutics Inc.
3.16%$5.56M
6EWTXEdgewise Therapeutics Inc.
3.10%$5.47M
7DFTXDefinium Therapeutics Inc.
2.75%$4.84M
8XENEXenon Pharmaceuticals Inc.
2.53%$4.45M
9VRDNViridian Therapeutics Inc.
2.48%$4.36M
10RLAYRelay Therapeutics Inc.
2.42%$4.27M
11TARSTarsus Pharmaceuticals Inc.
2.37%$4.17M
12AMLXAmylyx Pharmaceuticals Inc.
2.29%$4.03M
13ACADACADIA Pharmaceuticals Inc.
2.10%$3.70M
14SLSSELLAS Life Sciences Group Inc.
2.09%$3.67M
15DYNDyne Therapeutics Inc.
2.08%$3.67M

Total Holdings

104

Top 10 Weight

32.88%

Top Holding

CGON

Top Weight

5.04%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on18 funds
FundAsset classExpense ratioAssetsHoldings
SBIOALPS Medical Breakthroughs ETFThis fundEquity0.50%$187M103

Comparable funds

  • AFMCFirst Trust Active Factor Mid Cap ETFMid Cap Equity0.68%$256M267
  • EVXVanEck Environmental Services ETFEquity0.55%$101M27
  • FITEState Street SPDR S&P Kensho Future Security ETFEquity0.45%$150M78
  • IFGLiShares International Developed Real Estate ETFReal Estate (Listed/REITs)0.50%$81M258
  • PBJInvesco Food & Beverage ETFEquity0.64%$89M31
  • QISSimplify Multi-QIS Alternative ETFAlternatives1.13%$42M3,518

More ALPS Funds ETFs

  • CCNRALPS Funds CoreCommodity Natural Resources ETFEquity0.39%$423M295
  • DTECALPS Disruptive Technologies ETFEquity0.50%$71M101
  • EDOGALPS Emerging Sector Dividend Dogs ETFEquity0.60%$21M52
  • ELFYALPS Electrification Infrastructure ETFEquity0.50%$159M79
  • ENFRAlerian Energy Infrastructure ETFEquity0.35%$522M26
  • EQLALPS Equal Sector Weight ETFEquity0.19%$794M12
  • IDOGALPS International Sector Dividend Dogs ETFEquity0.50%$567M51
  • LGROLevel Four Large Cap Growth Active ETFEquity0.50%$141M46
  • MNBDALPS Intermediate Municipal Bond ETFFixed Income0.44%$56M131
  • OEFAALPS Funds O’Shares International Developed Quality Dividend ETFEquity0.48%$35M51
  • OGIGALPS Funds O’Shares Global Internet Giants ETFEquity0.48%$93M72
  • OUSAALPS Funds O’Shares U.S. Quality Dividend ETFEquity0.48%$750M101
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News